New drug class could treat range of cancers with faulty BRCA genes

(Institute of Cancer Research) - POLQ inhibitors identified as a new class of targeted drugs- New drug class can kill cancer cells with BRCA gene mutations and those that have become resistant to PARP inhibitors- POLQ inhibitor drug soon to be tested in clinical trials
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news